{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T15:12:39Z","timestamp":1785683559314,"version":"3.56.0"},"reference-count":222,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semdiagpath.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1053\/j.semdp.2016.11.003","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T03:16:49Z","timestamp":1481080609000},"page":"60-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Cutaneous EBV-related lymphoproliferative disorders"],"prefix":"10.1053","volume":"34","author":[{"given":"Alejandro A.","family":"Gru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2016.11.003_bib1","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semdp.2016.11.003_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","article-title":"Global trends in incidence and mortality of nasopharyngeal carcinoma","volume":"374","author":"Tang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1053\/j.semdp.2016.11.003_bib4","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1346-8138.12322","article-title":"Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disorders","volume":"41","author":"Park","year":"2014","journal-title":"J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-9-38","article-title":"Global burden of deaths from Epstein-Barr virus attributable malignancies 1990\u20132010","volume":"9","author":"Khan","year":"2014","journal-title":"Infect Agent Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib8","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1038\/onc.2009.258","article-title":"Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints","volume":"28","author":"Gruhne","year":"2009","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2016.11.003_bib9","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp Mol Med"},{"key":"10.1053\/j.semdp.2016.11.003_bib10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JVI.01512-10","article-title":"A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas","volume":"85","author":"Ma","year":"2011","journal-title":"J Virol"},{"key":"10.1053\/j.semdp.2016.11.003_bib11","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.2353\/ajpath.2009.080848","article-title":"Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications","volume":"174","author":"Balague","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib12","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/modpathol.2014.68","article-title":"In vivo intratumoral Epstein-Barr virus replication is associated with XBP1 activation and early-onset post-transplant lymphoproliferative disorders with prognostic implications","volume":"27","author":"Gonzalez-Farre","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib13","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1158\/1078-0432.CCR-13-0855","article-title":"PD-L1 expression is characteristic of a subset of aggressive B-cell lymphomas and virus-associated malignancies","volume":"19","author":"Chen","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2016.11.003_bib14","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The2016 revision of the world health organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib15","unstructured":"Nicolae A, Abdullah S, Davies-Hill T. et al. EBV+ B cell lymphomas (BCL) in young patients without immunodeficiency. In: Proceedings of the 17th Meeting of the European Association for Haematopathology, Istanbul, Turkey October 17\u201322, 2014; 2014."},{"key":"10.1053\/j.semdp.2016.11.003_bib16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer--a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib17","unstructured":"Ko YH, Chan JKC, Quintanilla-Martinez L: Virally Associated T-cell and NK-cell Neoplasms, in Jaffe ES, Arber DA, Campo E, et al. (eds.): Hematopathology (ed Second edition), 2016, pp 1 online resource"},{"key":"10.1053\/j.semdp.2016.11.003_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11899-009-0032-3","article-title":"Natural killer-cell neoplasms","volume":"4","author":"Greer","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1053\/j.semdp.2016.11.003_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1750-1172-8-95","article-title":"Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis","volume":"8","author":"Lima","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.semdp.2016.11.003_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","article-title":"Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients","volume":"16","author":"Cheung","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib21","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/1097-0142(20001115)89:10<2106::AID-CNCR11>3.0.CO;2-G","article-title":"Clinicopathologic and genotypic study of extranodal nasal-type natural killer\/T-cell lymphoma and natural killer precursor lymphoma among Koreans","volume":"89","author":"Ko","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/106689690401200410","article-title":"Nasal NK\/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities","volume":"12","author":"Kuo","year":"2004","journal-title":"Int J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib23","doi-asserted-by":"crossref","first-page":"575120","DOI":"10.5402\/2012\/575120","article-title":"Cutaneous T-cell lymphoma in asians","volume":"2012","author":"Jang","year":"2012","journal-title":"ISRN Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1099\/0022-1317-73-2-463","article-title":"Prevalence of the A and B types of Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from southern China","volume":"73","author":"Chen","year":"1992","journal-title":"J Gen Virol"},{"key":"10.1053\/j.semdp.2016.11.003_bib25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0021-9681(60)90067-9","article-title":"Radiotherapy of lethal mid-line granuloma","volume":"12","author":"Dickson","year":"1960","journal-title":"J Chronic Dis"},{"key":"10.1053\/j.semdp.2016.11.003_bib26","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pai.0000205062.27174.56","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru","volume":"15","author":"Barrionuevo","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2016.11.003_bib29","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1349-7006.2008.00768.x","article-title":"Phase I study of dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)\/T-cell lymphoma and leukemia","volume":"99","author":"Yamaguchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2016.11.003_bib30","first-page":"1063","article-title":"Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer\/T-cell lymphoma, nasal type","volume":"90","author":"Huang","year":"2005","journal-title":"Haematologica"},{"key":"10.1053\/j.semdp.2016.11.003_bib31","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","article-title":"Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell lymphoma Project","volume":"113","author":"Au","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib32","first-page":"36","article-title":"[Diagnostic value of serum levels of BamHI-W, LMP-1 and BZLF1 in NK\/T-cell lymphoma]","volume":"34","author":"Wang","year":"2013","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1053\/j.semdp.2016.11.003_bib33","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2012-06-435024","article-title":"Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK\/T-cell lymphoma patients receiving primary radiotherapy","volume":"120","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib34","first-page":"77","article-title":"Natural killer cell neoplasms","volume":"3","author":"Chan","year":"1998","journal-title":"Anat Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib35","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.23316","article-title":"Natural killer cell neoplasms","volume":"112","author":"Liang","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib36","series-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib37","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/MCG.0b013e31829e444f","article-title":"Prognostic characteristics of gastrointestinal tract NK\/T-cell lymphoma: an analysis of 47 patients in China","volume":"47","author":"Jiang","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.semdp.2016.11.003_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1756-8722-6-86","article-title":"Extranodal natural killer\/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma Study Group","volume":"6","author":"Kim","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1177\/1066896908316068","article-title":"Gastric involvement of extranodal NK\/T-cell lymphoma, nasal type: a report of 3 cases with literature review","volume":"16","author":"Zhang","year":"2008","journal-title":"Int J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib40","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12032-014-0218-y","article-title":"Prognostic significance of Ki-67 antigen expression in extranodal natural killer\/T-cell lymphoma, nasal type","volume":"31","author":"Jiang","year":"2014","journal-title":"Med Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib42","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/annonc\/mdm183","article-title":"Ki-67 expression is predictive of prognosis in patients with stage I\/II extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Kim","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: a report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib44","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2559.1997.2880887.x","article-title":"Nasal T\/NK cell lymphomas commonly express perforin and Fas ligand: important mediators of tissue damage","volume":"31","author":"Ohshima","year":"1997","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib45","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1182\/blood.V97.3.708","article-title":"Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T\/NK-cell lymphomas associated with the Epstein-Barr virus","volume":"97","author":"Nagata","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib46","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood.V81.10.2688.2688","article-title":"Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus","volume":"81","author":"Kanavaros","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib47","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1097\/00000478-199911000-00006","article-title":"Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital","volume":"23","author":"Cuadra-Garcia","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib49","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-016-2011-0","article-title":"Expression of programmed cell death ligand 1 (PD-L1) in advanced stage EBV-associated extranodal NK\/T cell lymphoma is associated with better prognosis","volume":"469","author":"Kim","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1053\/j.semdp.2016.11.003_bib50","article-title":"Expression of programmed cell death 1 and programmed cell death ligand 1 in extranodal NK\/T-cell lymphoma, nasal type","author":"Jo","year":"2016","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib51","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","article-title":"PD-L1 is upregulated by EBV-driven LMP1 through NF-kappaB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma","volume":"9","author":"Bi","year":"2016","journal-title":"J Hematol Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib52","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","article-title":"Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies","volume":"38","author":"Swerdlow","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.humpath.2014.11.008","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors","volume":"46","author":"Jhuang","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib54","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1053\/j.semdp.2016.11.003_bib55","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3109\/10428194.2013.819577","article-title":"Rare occurrence of JAK3 mutations in natural killer cell neoplasms in Japan","volume":"55","author":"Kimura","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2016.11.003_bib56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/pin.12166","article-title":"Activated janus kinase 3 expression not by activating mutations identified in natural killer\/T-cell lymphoma","volume":"64","author":"Guo","year":"2014","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2016.11.003_bib57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","article-title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma","volume":"28","author":"Bouchekioua","year":"2014","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2016.11.003_bib58","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood-2009-05-221275","article-title":"Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK\/T-cell lymphoma, nasal type","volume":"115","author":"Huang","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib59","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/leu.2009.91","article-title":"STAT3 transcription factor is constitutively activated and is oncogenic in nasal-type NK\/T-cell lymphoma","volume":"23","author":"Coppo","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2016.11.003_bib60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cellsig.2008.09.006","article-title":"BCR-ABL induces opposite phenotypes in murine ES cells according to STAT3 activation levels","volume":"21","author":"Coppo","year":"2009","journal-title":"Cell Signal"},{"key":"10.1053\/j.semdp.2016.11.003_bib61","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1182\/blood-2014-07-588970","article-title":"Receptor-type tyrosine-protein phosphatase kappa directly targets STAT3 activation for tumor suppression in nasal NK\/T-cell lymphoma","volume":"125","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib62","first-page":"265","article-title":"P53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK\/T-cell lymphoma in Korea and Japan","volume":"13","author":"Hongyo","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1053\/j.semdp.2016.11.003_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1349-7006.2003.tb01436.x","article-title":"Analysis of p53, K-ras, c-kit, and beta-catenin gene mutations in sinonasal NK\/T cell lymphoma in northeast district of China","volume":"94","author":"Hoshida","year":"2003","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2016.11.003_bib64","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0002-9440(10)63061-1","article-title":"P53 Mutations in nasal natural killer\/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease","volume":"159","author":"Quintanilla-Martinez","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib65","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2016.11.003_bib66","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1182\/blood-2011-04-346890","article-title":"Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses","volume":"118","author":"Karube","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib67","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Kucuk","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.semdp.2016.11.003_bib68","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.humpath.2003.08.025","article-title":"P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK\/T-cell lymphoma from Hokkaido, Japan","volume":"35","author":"Takahara","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib69","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64490-2","article-title":"Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer\/T-cell lymphoma","volume":"161","author":"Shen","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib70","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/sj.onc.1205571","article-title":"Frequent mutations of Fas gene in nasal NK\/T cell lymphoma","volume":"21","author":"Takakuwa","year":"2002","journal-title":"Oncogene"},{"key":"10.1053\/j.semdp.2016.11.003_bib71","first-page":"2345","article-title":"Specific c-kit mutations in sinonasal natural killer\/T-cell lymphoma in China and Japan","volume":"60","author":"Hongyo","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.semdp.2016.11.003_bib72","doi-asserted-by":"crossref","first-page":"e91521","DOI":"10.1371\/journal.pone.0091521","article-title":"An A91V SNP in the perforin gene is frequently found in NK\/T-cell lymphomas","volume":"9","author":"Manso","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.semdp.2016.11.003_bib73","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1600-0609.2005.00417.x","article-title":"Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1\/Cip1, p27Kip1 and p73) in natural killer cell disorders","volume":"74","author":"Kawamata","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-2141.2003.04396.x","article-title":"Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas","volume":"122","author":"Siu","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib75","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0002-9440(10)64349-0","article-title":"Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved","volume":"160","author":"Siu","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib76","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/leu.2010.255","article-title":"Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro","volume":"25","author":"Iqbal","year":"2011","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2016.11.003_bib77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cyto.1069","article-title":"Comparative genomic hybridization study of nasal-type NK\/T-cell lymphoma","volume":"46","author":"Ko","year":"2001","journal-title":"Cytometry"},{"key":"10.1053\/j.semdp.2016.11.003_bib78","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/gcc.20245","article-title":"Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma\/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal NK\/T-cell lymphoma, nasal type","volume":"44","author":"Nakashima","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cancergencyto.2005.06.025","article-title":"Chromosome band 6q deletion pattern in malignant lymphomas","volume":"165","author":"Taborelli","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1053\/j.semdp.2016.11.003_bib80","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib81","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/DAD.0000000000000011","article-title":"Pediatric CD8(+)CD56(+) non-poikilodermatous mycosis fungoides: case report and review of the literature","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib82","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cup.12452","article-title":"Childhood mycosis fungoides with a CD8+ CD56+ cytotoxic immunophenotype","volume":"42","author":"Poppe","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib83","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: clinical, pathologic, and genetic features","author":"Nicolae","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000000312","article-title":"Primary cutaneous NK\/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia","volume":"39","author":"Takata","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib85","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib86","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/157.3.405","article-title":"The chronic mononucleosis syndrome","volume":"157","author":"Straus","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2016.11.003_bib87","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1086\/367988","article-title":"Prognostic factors for chronic active Epstein-Barr virus infection","volume":"187","author":"Kimura","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2016.11.003_bib88","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3346\/jkms.2008.23.2.185","article-title":"The spectrum of Epstein-Barr virus-associated lymphoproliferative disease in Korea: incidence of disease entities by age groups","volume":"23","author":"Cho","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1053\/j.semdp.2016.11.003_bib90","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4132\/KoreanJPathol.2013.47.2.137","article-title":"EBV-positive T\/NK-cell lymphoproliferative disease of childhood","volume":"47","author":"Hong","year":"2013","journal-title":"Korean J Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib91","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","article-title":"Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD","volume":"58","author":"Ohshima","year":"2008","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2016.11.003_bib92","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1128\/CMR.4.1.129","article-title":"Severe chronic active Epstein-Barr virus infection syndrome","volume":"4","author":"Okano","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.semdp.2016.11.003_bib93","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","article-title":"Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008","volume":"20","author":"Cohen","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib94","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1053\/j.semdp.2016.11.003_bib95","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1349-7006.1997.tb00305.x","article-title":"Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells","volume":"88","author":"Ishihara","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"10.1053\/j.semdp.2016.11.003_bib96","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V98.10.3173","article-title":"Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease","volume":"98","author":"Kawa","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib97","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1016\/j.jinf.2005.08.035","article-title":"Epstein-Barr virus infected natural killer cell lymphoma in a patient with hypersensitivity to mosquito bite","volume":"52","author":"Cho","year":"2006","journal-title":"J Infect"},{"key":"10.1053\/j.semdp.2016.11.003_bib98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3904\/kjim.2003.18.1.50","article-title":"Hypersensitivity to mosquito bites associated with natural killer cell-derived large granular lymphocyte lymphocytosis: a case report in Korea","volume":"18","author":"Chung","year":"2003","journal-title":"Korean J Intern Med"},{"key":"10.1053\/j.semdp.2016.11.003_bib99","first-page":"420","article-title":"Hypersensitivity to mosquito bite: a case report","volume":"11","author":"Fan","year":"1995","journal-title":"Gaoxiong Yi Xue Ke Xue Za Zhi"},{"key":"10.1053\/j.semdp.2016.11.003_bib100","first-page":"303","article-title":"Hypersensitivity to mosquito bite and malignant histocytosis","volume":"52","author":"Hidano","year":"1982","journal-title":"Jpn J Exp Med"},{"key":"10.1053\/j.semdp.2016.11.003_bib101","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S","article-title":"Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites","volume":"54","author":"Ishihara","year":"1997","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib102","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1651-2227.1995.tb13547.x","article-title":"Chronic active Epstein-Barr virus infection in children in Japan","volume":"84","author":"Ishihara","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.semdp.2016.11.003_bib103","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/000155501317140106","article-title":"A case of exaggerated mosquito-bite hypersensitivity with Epstein-Barr virus-positive inflammatory cells in the bite lesion","volume":"81","author":"Ohsawa","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.semdp.2016.11.003_bib104","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/archderm.1990.01670270094016","article-title":"Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"issue":"639\u201342","key":"10.1053\/j.semdp.2016.11.003_bib105","first-page":"629","article-title":"[Mosquito bite allergies terminating as hemophagocytic histiocytosis: report of a case]","volume":"88","author":"Tsai","year":"1989","journal-title":"Taiwan Yi Xue Hui Za Zhi"},{"key":"10.1053\/j.semdp.2016.11.003_bib106","first-page":"223","article-title":"Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease","volume":"72","author":"Ishihara","year":"2000","journal-title":"Int J Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib107","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.0022-202X.2005.23915.x","article-title":"Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites","volume":"125","author":"Asada","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib108","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1349-7006.2005.00076.x","article-title":"Enhanced T-cell response to mosquito extracts by NK cells in hypersensitivity to mosquito bites associated with EBV infection and NK cell lymphocytosis","volume":"96","author":"Tokura","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2016.11.003_bib109","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1067\/mjd.2001.114751","article-title":"Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia\/lymphoma","volume":"45","author":"Tokura","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0190-9622(00)90127-0","article-title":"Hydroa vacciniforme: a clinical and follow-up study of 17 cases","volume":"42","author":"Gupta","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib111","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"issue":"Suppl 3","key":"10.1053\/j.semdp.2016.11.003_bib112","first-page":"657","article-title":"Hypersensitivity to mosquito bites and hydroa vacciniforme","volume":"64","author":"Iwatsuki","year":"2006","journal-title":"Nihon Rinsho"},{"key":"10.1053\/j.semdp.2016.11.003_bib113","series-title":"EBV+ T-cell lymphoproliferative disorders of childhood","author":"Quintanilla-Martinez","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib114","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/ajh.23843","article-title":"Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: report of four pediatric cases from Peru","volume":"89","author":"Beltran","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib116","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2340\/00015555-0670","article-title":"Antiviral therapy in children with hydroa vacciniforme","volume":"89","author":"Lysell","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.semdp.2016.11.003_bib117","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2165\/00128071-200910030-00003","article-title":"Immunologically mediated photodermatoses: diagnosis and treatment","volume":"10","author":"Gambichler","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib118","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2016.11.003_bib119","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1097\/MPH.0000000000000221","article-title":"Hydroa vacciniforme-like lymphoma: a case report from India","volume":"37","author":"Boddu","year":"2015","journal-title":"J Pedia Hematol Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib120","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0190-9622(99)70210-0","article-title":"Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy","volume":"40","author":"Iwatsuki","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib121","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0190-9622(98)70120-3","article-title":"Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma","volume":"38","author":"Magana","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib122","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/archderm.1986.01660230098020","article-title":"Coexistence of hydroa vacciniforme and malignant lymphoma","volume":"122","author":"Oono","year":"1986","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib123","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/DAD.0000000000000158","article-title":"Hydroa vacciniforme-like lymphoma with primarily periorbital swelling: 7 cases of an atypical clinical manifestation of this rare cutaneous T-cell lymphoma","volume":"37","author":"Plaza","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib124","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1097\/PAS.0b013e3181fbb4fd","article-title":"EBV-associated cutaneous NK\/T-cell lymphoma: review of a series of 14 cases from peru in children and young adults","volume":"34","author":"Rodriguez-Pinilla","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jaad.2013.01.037","article-title":"Hydroa vacciniforme-like cutaneous T-cell lymphoma: clinicopathologic and immunohistochemical study of 12 cases","volume":"69","author":"Sangueza","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib126","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2002.04862.x","article-title":"Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib127","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1365-4632.2007.03102.x","article-title":"Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child","volume":"46","author":"Wu","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib128","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2133.2004.06038.x","article-title":"Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases","volume":"151","author":"Cho","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib129","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1348-0421.2003.tb03416.x","article-title":"Characterization of Epstein-Barr virus (EBV)-positive NK cells isolated from hydroa vacciniforme-like eruptions","volume":"47","author":"Demachi","year":"2003","journal-title":"Microbiol Immunol"},{"key":"10.1053\/j.semdp.2016.11.003_bib130","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2133.2005.06849.x","article-title":"The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles","volume":"153","author":"Morizane","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib131","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","article-title":"Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions","volume":"121","author":"Zhang","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib132","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.oooo.2015.06.028","article-title":"EBV-positive mucocutaneous ulcer of the oral cavity associated with HIV\/AIDS","volume":"120","author":"Bunn","year":"2015","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radio"},{"key":"10.1053\/j.semdp.2016.11.003_bib133","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ccr3.287","article-title":"Age-related Epstein-Barr virus-positive mucocutaneous ulcer: a case report","volume":"3","author":"Magalhaes","year":"2015","journal-title":"Clin Case Rep"},{"key":"10.1053\/j.semdp.2016.11.003_bib134","doi-asserted-by":"crossref","first-page":"6072","DOI":"10.3748\/wjg.v21.i19.6072","article-title":"Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease","volume":"21","author":"Moran","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.semdp.2016.11.003_bib135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semdp.2014.12.003","article-title":"Human papillomavirus and Epstein-Barr virus associated conditions of the oral mucosa","volume":"32","author":"Stojanov","year":"2015","journal-title":"Semin Diagn Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib136","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/PAS.0000000000000225","article-title":"Methotrexate-associated B-cell lymphoproliferative disorders presenting in the skin: a clinicopathologic and immunophenotypical study of 10 cases","volume":"38","author":"Koens","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib137","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1097\/PAS.0000000000000282","article-title":"EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder","volume":"38","author":"Hart","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib138","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/bmt.2015.245","article-title":"Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer","volume":"51","author":"Nelson","year":"2016","journal-title":"Bone Marrow Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib139","article-title":"EBV-positive mucocutaneous ulcer arising in a post-hematopoietic cell transplant patient followed by polymorphic post-transplant lymphoproliferative disorder and cytomegalovirus colitis","author":"Satou","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib140","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1182\/blood-2008-06-164806","article-title":"Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients","volume":"113","author":"Asano","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib141","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1440-1827.2009.02466.x","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity","volume":"59","author":"Shimoyama","year":"2009","journal-title":"Pathol Int"},{"key":"10.1053\/j.semdp.2016.11.003_bib142","series-title":"EBV positive diffuse large B-cell lymphoma of the elderly","author":"Nakamura","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib143","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1349-7006.2008.00813.x","article-title":"Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease","volume":"99","author":"Shimoyama","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1053\/j.semdp.2016.11.003_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":"Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J Clin Exp Hematop"},{"key":"10.1053\/j.semdp.2016.11.003_bib145","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ced.12322","article-title":"Epstein-Barr virus-positive diffuse large B-cell lymphoma in an elderly patient","volume":"39","author":"De Unamuno Bustos","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib146","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib147","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1258\/ijsa.2011.011235","article-title":"Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature","volume":"22","author":"Corti","year":"2011","journal-title":"Int J STD AIDS"},{"key":"10.1053\/j.semdp.2016.11.003_bib148","series-title":"Plasmablastic lymphoma","author":"Stein","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib149","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1440-0960.2012.00939.x","article-title":"Post-transplant plasmablastic lymphoma of the skin","volume":"54","author":"Black","year":"2013","journal-title":"Austral J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","article-title":"Plasmablastic lymphoma arising at a cutaneous site","volume":"46","author":"Jordan","year":"2005","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib151","first-page":"267","article-title":"Epidermodysplasia verruciformis associated with plasmablastic lymphoma and hepatitis B virus infection","volume":"20","author":"Shayanfar","year":"2012","journal-title":"Acta Derm Croat"},{"key":"10.1053\/j.semdp.2016.11.003_bib152","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-3046.2008.01026.x","article-title":"Multifocal cutaneous and systemic plasmablastic lymphoma in an infant with combined living donor small bowel and liver transplant","volume":"13","author":"Apichai","year":"2009","journal-title":"Pedia Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0242-6498(05)80098-7","article-title":"Plasmablastic lymphoma in a patient with HIV infection: an unusual case located in the skin","volume":"25","author":"Dales","year":"2005","journal-title":"Ann Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib154","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.1016\/j.jaad.2013.06.050","article-title":"Primary cutaneous plasmablastic lymphoma in an immunocompetent patient","volume":"69","author":"Horna","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib155","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2007.08.009","article-title":"Cutaneous plasmablastic lymphoma","volume":"58","author":"Jambusaria","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib156","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib157","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib158","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1365-2559.2012.04339.x","article-title":"Plasmablastic lymphoma of the elderly: a clinicopathological comparison with age-related Epstein-Barr virus-associated B cell lymphoproliferative disorder","volume":"61","author":"Liu","year":"2012","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib159","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib160","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0001-7310(05)73107-0","article-title":"[Specific cutaneous involvement in patients with multiple myeloma. A clinicopathological, immunohistochemical and cytogenetic study of 40 cases]","volume":"96","author":"Requena","year":"2005","journal-title":"Actas Dermosifiliogr"},{"key":"10.1053\/j.semdp.2016.11.003_bib161","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1309\/27H8XJH31F3GUNAT","article-title":"Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV","volume":"128","author":"Chang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib162","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2350\/12-05-1187-CR.1","article-title":"Plasma cell myeloma associated with Epstein-Barr virus infection in an 11-year-old girl","volume":"15","author":"Garcia-Alvarez","year":"2012","journal-title":"Pedia Dev Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib163","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.20048","article-title":"Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients","volume":"76","author":"Boulanger","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib164","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib165","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12405","article-title":"Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma","author":"Crane","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib166","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/DAD.0b013e31829beaa7","article-title":"Cutaneous double-hit B-cell lymphoma: an aggressive form of B-cell lymphoma with a propensity for cutaneous dissemination","volume":"36","author":"Magro","year":"2014","journal-title":"Am J Derm"},{"key":"10.1053\/j.semdp.2016.11.003_bib167","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1097\/PAS.0b013e3181fd8781","article-title":"Lymphomatoid granulomatosis: insights gained over 4 decades","volume":"34","author":"Katzenstein","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib168","series-title":"Lymphomatoid granulomatosis","author":"Pittaluga","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/PAS.0000000000000328","article-title":"Lymphomatoid granulomatosis--a single institute experience: pathologic findings and clinical correlations","volume":"39","author":"Song","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib170","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0046-8177(72)80005-4","article-title":"Lymphomatoid granulomatosis","volume":"3","author":"Liebow","year":"1972","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib171","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2014.07.035","article-title":"Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors","volume":"72","author":"Eminger","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib172","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/DAD.0b013e318289b20e","article-title":"Cutaneous lymphomas: an update. Part 2: b-cell lymphomas and related conditions","volume":"36","author":"Kempf","year":"2014","journal-title":"Am J Derm"},{"key":"10.1053\/j.semdp.2016.11.003_bib173","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-4362.1994.tb04969.x","article-title":"Lymphomatoid granulomatosis","volume":"33","author":"Magro","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib174","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/archderm.1975.01630160083009","article-title":"Lymphomatoid granulomatosis of the skin. A new clinocopathologic entity","volume":"111","author":"Minars","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib175","article-title":"Lymphomatoid granulomatosis presenting with cutaneous involvement: a case report and review of the literature","author":"Rysgaard","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib176","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcp\/106.1.69","article-title":"Angiocentric immunoproliferative lesions of the lymph node","volume":"106","author":"Takeshita","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib177","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jaad.2005.11.1066","article-title":"Posttransplantation lymphoproliferative disease with features of lymphomatoid granulomatosis in a lung transplant patient","volume":"54","author":"Kwon","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib178","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1346-8138.2010.01186.x","article-title":"Cutaneous lesion of lymphomatoid granulomatosis in a Korean woman with secondary myelofibrosis","volume":"38","author":"Park","year":"2011","journal-title":"J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib179","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/jcp.56.7.555","article-title":"Isolated EBV lymphoproliferative disease in a child with Wiskott-Aldrich syndrome manifesting as cutaneous lymphomatoid granulomatosis and responsive to anti-CD20 immunotherapy","volume":"56","author":"Sebire","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib180","first-page":"488","article-title":"[Primary and isolated cutaneous lymphomatoid granulomatosis following heart-lung transplantation]","volume":"127","author":"Tas","year":"2000","journal-title":"Ann Dermatol Venereol"},{"key":"10.1053\/j.semdp.2016.11.003_bib181","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2133.1984.tb04688.x","article-title":"Cutaneous lymphomatoid granulomatosis: a rare cause of recurrent skin ulceration","volume":"110","author":"Wood","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib182","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1471-230X-14-127","article-title":"Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease","volume":"14","author":"Connors","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.semdp.2016.11.003_bib183","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1200\/JCO.2012.46.2770","article-title":"Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis","volume":"31","author":"Ochi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib184","first-page":"321","article-title":"[Methotrexate-related lymphomatoid granulomatosis successfully treated with discontinuation of methotrexate and radiotherapy to brain]","volume":"55","author":"Yamakawa","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"10.1053\/j.semdp.2016.11.003_bib185","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archderm.143.9.1222","article-title":"Lymphomatoid granulomatosis induced by imatinib-treatment","volume":"143","author":"Yazdi","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib186","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1200\/JCO.2012.47.4999","article-title":"Long-term remission after multiple relapses in an elderly patient with lymphomatoid granulomatosis after rituximab and high-dose cytarabine chemotherapy without stem-cell transplantation","volume":"31","author":"Aoki","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib187","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archderm.1981.01650040012011","article-title":"Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature","volume":"117","author":"James","year":"1981","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib188","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11899-012-0132-3","article-title":"Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes","volume":"7","author":"Dunleavy","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1053\/j.semdp.2016.11.003_bib189","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1182\/blood.V72.5.1674.1674","article-title":"Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations","volume":"72","author":"Lipford","year":"1988","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2016.11.003_bib190","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2559.1994.tb01373.x","article-title":"Epstein-Barr virus in cutaneous lymphomatoid granulomatosis","volume":"25","author":"Angel","year":"1994","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib191","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1097-0142(197901)43:1<360::AID-CNCR2820430151>3.0.CO;2-8","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases","volume":"43","author":"Katzenstein","year":"1979","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2016.11.003_bib192","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00000478-199809000-00008","article-title":"Proliferation and cellular phenotype in lymphomatoid granulomatosis: implications of a higher proliferation index in B cells","volume":"22","author":"Guinee","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib193","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00313028609059478","article-title":"Lymphomatoid granulomatosis: a clinicopathologic study of 42 patients","volume":"18","author":"Koss","year":"1986","journal-title":"Pathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib194","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-4362.1994.tb04947.x","article-title":"Lymphomatoid granulomatosis presenting as a solitary cutaneous lesion","volume":"33","author":"Tawfik","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib195","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/0190-9622(92)70270-P","article-title":"Lymphomatoid granulomatosis","volume":"27","author":"Tong","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib196","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0733-8635(18)30505-9","article-title":"Granulomatous vasculitides and the skin","volume":"8","author":"Gibson","year":"1990","journal-title":"Dermatol Clin"},{"key":"10.1053\/j.semdp.2016.11.003_bib197","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.1994.01690070055008","article-title":"Wegener's granulomatosis. Dermatological manifestations in 75 cases with clinicopathologic correlation","volume":"130","author":"Frances","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib198","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1600-0560.2011.01829.x","article-title":"Azathioprine-induced EBV-positive mucocutaneous ulcer","volume":"39","author":"McGinness","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib199","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0463.2012.02939.x","article-title":"EBV+ cutaneous B-cell lymphoproliferation of the leg in an elderly patient with mycosis fungoides and methotrexate treatment","volume":"121","author":"Rausch","year":"2013","journal-title":"APMIS"},{"key":"10.1053\/j.semdp.2016.11.003_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2013.06.011","article-title":"Primary cutaneous B-cell lymphomas: part I. clinical features, diagnosis, and classification","volume":"69","author":"Suarez","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib201","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1309\/AJCPNLC9NC9WTQYY","article-title":"Cutaneous B-cell lymphoproliferative disorders: report of the 2011 Society for Hematopathology\/European Association for Haematopathology workshop","volume":"139","author":"Swerdlow","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib202","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Opelz","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/j.semdp.2016.11.003_bib203","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJM199012203232510","article-title":"Cancers complicating organ transplantation","volume":"323","author":"Penn","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2016.11.003_bib204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1600-0560.2009.01449.x","article-title":"Cutaneous presentation of post-renal transplant lymphoproliferative disorder: a series of four cases","volume":"37","author":"Salama","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib205","series-title":"Post-transplant lymphoproliferative disorders","author":"Swerdlow","year":"2008"},{"key":"10.1053\/j.semdp.2016.11.003_bib206","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1600-6143.2011.03893.x","article-title":"Associations between EBV serostatus and organ transplant type in PTLD risk: an analysis of the SRTR National Registry Data in the United States","volume":"12","author":"Dharnidharka","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib207","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1200\/JCO.2008.20.0857","article-title":"Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center","volume":"27","author":"Knight","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib208","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1053\/j.semdp.2016.11.003_bib209","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1200\/JCO.1995.13.4.961","article-title":"Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center","volume":"13","author":"Leblond","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2016.11.003_bib210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1525-1470.2009.01019.x","article-title":"Cutaneous presentation of plasmablastic post-transplant lymphoproliferative disorder in a 14-month-old","volume":"26","author":"Hernandez","year":"2009","journal-title":"Pedia Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib211","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/DAD.0b013e31823067f8","article-title":"Composite B-cell and T-cell lineage post-transplant lymphoproliferative disorder of the lung with unusual cutaneous manifestations of mycosis fungoides","volume":"34","author":"Mills","year":"2012","journal-title":"Am J Derm"},{"key":"10.1053\/j.semdp.2016.11.003_bib212","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1111\/ajt.12281","article-title":"Primary cutaneous posttransplant lymphoproliferative disorders in solid organ transplant recipients: a multicenter European case series","volume":"13","author":"Seckin","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib213","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0b013e3182190999","article-title":"EBV-Positive Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue in the Posttransplant Setting: a Distinct Type of Posttransplant Lymphoproliferative Disorder?","volume":"35","author":"Gibson","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2016.11.003_bib214","article-title":"Presentation and management of post-allogeneic transplantation EBV-positive mucocutaneous ulcer","author":"Nelson","year":"2015","journal-title":"Bone Marrow Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib215","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3109\/10428194.2013.775436","article-title":"Clinicopathological characteristics of posttransplant lymphoproliferative disorders of T-cell origin: single-center series of nine cases and meta-analysis of 147 reported cases","volume":"54","author":"Herreman","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2016.11.003_bib216","doi-asserted-by":"crossref","DOI":"10.5070\/D3207023132","article-title":"CD30 expression in cutaneous B-cell and post-transplant peripheral T-cell lymphoma: report of 2 cases","volume":"20","author":"Albrecht","year":"2014","journal-title":"Dermatol Online J"},{"key":"10.1053\/j.semdp.2016.11.003_bib217","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2340\/00015555-0543","article-title":"Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review","volume":"89","author":"Belloni-Fortina","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1053\/j.semdp.2016.11.003_bib218","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/j.1365-2230.2008.03145.x","article-title":"Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient","volume":"34","author":"Chiu","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.semdp.2016.11.003_bib219","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2559.2004.01847.x","article-title":"Post-transplant T-cell lymphoproliferative disorder\/T-cell lymphoma: a report of three cases of T-anaplastic large-cell lymphoma with cutaneous presentation and a review of the literature","volume":"44","author":"Coyne","year":"2004","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2016.11.003_bib220","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.critrevonc.2004.12.012","article-title":"Post-transplant cutaneous T-cell lymphomas","volume":"56","author":"Lok","year":"2005","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1053\/j.semdp.2016.11.003_bib221","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1600-6143.2004.00586.x","article-title":"EBV positive primary cutaneous CD30+ large T-cell lymphoma in a heart transplanted patient: case report","volume":"4","author":"Lucioni","year":"2004","journal-title":"Am J Transpl"},{"key":"10.1053\/j.semdp.2016.11.003_bib222","doi-asserted-by":"crossref","first-page":"e778","DOI":"10.1111\/j.1365-2230.2009.03509.x","article-title":"Primary cutaneous T-cell lymphoproliferative disorder of donor origin after allogeneic haematopoietic stem-cell transplantation","volume":"34","author":"Santos-Briz","year":"2009","journal-title":"Clin Exp Dermatol"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016300934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257016300934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T12:50:52Z","timestamp":1657975852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257016300934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":222,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0740257016300934"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2016.11.003","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous EBV-related lymphoproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semdp.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}